Path clear for acellular pertussis vaccines

Noteworthy

Path clear for acellular pertussis vaccines

Positive results in two large trials of several acellular pertussis vaccines have validated the technology, and is likely to result in rapid approval of the new vaccines to replace the currently marketed whole killed vaccines.

The National Institute of Allergy and Infectious Diseases (NIAID) announced results of Phase III trials of acellular pertussis vaccines in Italy

Read the full 632 word article

How to gain access

Continue reading with a
two-week free trial.